文献速递心脑血管急症

引入高敏肌钙蛋白可缩短急诊科停留时间

Introduction of a high sensitivity troponin reduces ED length of stay.
PubMed 文献 · Am J Emerg Med · 2023-11-21
一句话结论从第4代肌钙蛋白转换为第5代高敏肌钙蛋白T后,胸痛患者离院和住院的急诊停留时间分别缩短47分钟和77分钟,收住院率和冠脉造影率未增加。

该研究为实用性前瞻性前后对照研究,在大型郊区学术医疗中心比较第4代肌钙蛋白与第5代高敏肌钙蛋白T(Elecsys® Troponin T-high sensitive, Roche Diagnostics)转换前后3个月所有成人急诊胸痛患者的电子健康记录。转换前后分别纳入1431例和1437例胸痛患者。直接离院患者急诊停留时间中位数从6.2小时降至5.3小时,差异47分钟(95%CI 35-59),P<0.001;收住院患者从9.5小时降至8.1小时,差异77分钟(95%CI 35-121),P<0.001。总体收住院率(前后均为22% vs 21%)及CT冠脉造影率(21% vs 20.4%)、有创冠脉造影率(5.8% vs 5.6%)无变化。

要点

  • 胸痛患者直接离院者急诊停留时间中位数:转换前6.2小时(IQR 4.7-8.4) vs 转换后5.3小时(IQR 4.0-7.2),缩短47分钟(95%CI 35-59),P<0.001。
  • 胸痛患者收住院者急诊停留时间中位数:转换前9.5小时(IQR 6.6-13.8) vs 转换后8.1小时(IQR 5.7-11.2),缩短77分钟(95%CI 35-121),P<0.001。
  • 转换前后总体收住院率分别为22%和21%,无变化。
  • 转换前后CT冠脉造影率分别为21%和20.4%,有创冠脉造影率分别为5.8%和5.6%。

适用人群与场景

  • 大型郊区学术医疗中心所有成人急诊胸痛患者,转换前3个月1431例,转换后3个月1437例。
  • 平均(SD)年龄分别为51.5(18)岁和54.3(18)岁,女性分别占54.3%。

研究设计与关键结果

  • 实用性前瞻性前后对照研究,在大型郊区学术医疗中心比较第4代肌钙蛋白与第5代高敏肌钙蛋白T(Elecsys® Troponin T-high sensitive, Roche Diagnostics, Indianapolis, IN)转换前后3个月胸痛患者的急诊停留时间。
  • 直接离院胸痛患者急诊停留时间中位数(IQR):转换前6.2(4.7-8.4)小时 vs 转换后5.3(4.0-7.2)小时,差异47分钟(95%CI 35-59),P<0.001。
  • 收住院胸痛患者急诊停留时间中位数(IQR):转换前9.5(6.6-13.8)小时 vs 转换后8.1(5.7-11.2)小时,差异77分钟(95%CI 35-121),P<0.001。
  • 总体收住院率转换前22% vs 转换后21%,无变化。
  • CT冠脉造影率转换前21% vs 转换后20.4%;有创冠脉造影率转换前5.8% vs 转换后5.6%。

证据类型、等级与局限

  • 证据类型:实用性前瞻性前后对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,转换为高敏肌钙蛋白T与胸痛患者(无论是否收住院)急诊停留时间具有临床相关且统计学显著的缩短有关,且收住院率或冠脉造影率未增加。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: High sensitivity cardiac troponins (hs-cTn) allow earlier identification and exclusion of acute myocardial infarction. We determined if transitioning from contemporary to high sensitivity troponin T (hs-cTnT) would reduce ED length of stay in chest pain (CP) patients.

METHODS: We conducted a pragmatic, prospective, before and after study of implementing a hs-cTnT by reviewing the electronic health records in all adult ED patients presenting to a large, suburban academic medical center during the 3 months before and after transitioning from a 4th generation troponin to a 5th generation hs-cTnT (Elecsys® Troponin T-high sensitive, Roche Diagnostics, Indianapolis, IN).

RESULTS: There were 1431 and 1437 CP patients before and after the intervention. Mean (SD) age was 51.5 (18) yrs. and 54.3% were female. The median (IQR) ED LOS for chest pain patients directly discharged to home was 6.2 (4.7-8.4) and 5.3 (4.0-7.2) hours before and after introducing hs-cTn respectively; difference 47 min (95%CI, 35-59); P < 0.001. The median (IQR) ED LOS for chest pain patients admitted to the hospital was 9.5 (6.6-13.8) and 8.1 (5.7-11.2) hours before and after introducing hs-cTn respectively; difference 77 min (95%CI, 35-121); P < 0.001. Overall admission rates (22 vs 21% both before and after) did not change during the study. The rates of computed tomography coronary angiography before and after the intervention were 21 and 20.4% respectively. The rates of invasive coronary angiography before and after the intervention were 5.8 and 5.6% respectively.

CONCLUSIONS: Transitioning to a hs-cTnT is associated with a clinically relevant and statistically significant reduction in ED LOS for both discharged and admitted patients with and without CP with no increase in admission or coronary angiography rates.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Singer AJ, Heslin S, Skopicki H, et al. Introduction of a high sensitivity troponin reduces ED length of stay. Am J Emerg Med. 2023. PMID: 38006636. doi:10.1016/j.ajem.2023.11.028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。